Directory snapshot
Raleigh biotech startups by stage
Of 3 startups with a recorded funding stage, 1 are at grant, pre-seed, or seed.
- tracked startups
- 10
- hiring now
- 0
- grant through seed
- 1
All 10 biotech startups headquartered in Raleigh
Aer Therapeutics
Biotech
Biotech developing inhaled therapies that target mucus obstruction in chronic lung disease. Spun out of UCSF.
Bedrock Therapeutics
Biotech
Develops engineered AAV vectors and gene therapies, with programs in corneal transplant rejection, ocular graft-versus-host disease, macular degeneration and rheumatoid arthritis.
Belhaven Biopharma
Biotech · Growth
Developing Nasdepi, a dry powder nasal epinephrine product for severe allergic reactions.
ChromaGenix
Biotech
Bioprocessing tooling startup developing synthetic peptide ligands for affinity chromatography of advanced biologic modalities (gene therapies, mRNA vaccines, exosomes, lipid nanoparticles, AAV vectors). Formed in 2025-04-22 by BioProcess360 Partners through transfer of IP, assets, and personnel from LigaTrap Technologies.
Gemelli Biotech
Biotech
At-home precision diagnostics for GI diseases.
MicroBioCol
Biotech
Raleigh software startup building CadeLume, an auditable AI proxy gateway designed for regulated biopharma teams.
NOBiotics, LLC
Biotech
Develops nitric oxide based therapeutics and medical devices, including topical therapies and dressings for wound infection control.
Oncurie
Biotech
NC State spinout developing chelator-based radiopharmaceuticals that carry radioactive isotopes to cancer cells, starting with ovarian cancer.
Slate Medicines
Biotech · Series A
Raleigh biotech developing therapeutics for migraine and other headache disorders. Lead program SLTE-1009 is a subcutaneous anti-PACAP monoclonal antibody in-licensed from DartsBio Pharmaceuticals, targeting a pathway distinct from CGRP.
Synoxa Sciences
Biotech · Pre-seed
Discovery-stage antibiotic small-molecule company developing two novel chemical classes (4-oxazolidiones and a class targeting multidrug-resistant Gram-negative pathogens). NC State spinout from the Joshua Pierce lab.
Exited biotech companies headquartered in Raleigh
These companies have been acquired, taken private, or taken public, so each is listed with its exit and left out of the startup count above.
Browsing is free. Opening a company shows the basics; founders, funding, and signals are in the full profile behind a free account. Open roles across Triangle companies are tracked on the jobs page. Numbers refresh from the database.